Twenty-three nondiabetic volunteers were divided into three groups. In group A (n ‫؍‬ 9), the glucose infusion was adjusted to maintain blood glucose at 5 mmol/l (euglycemic clamp). In group B (n ‫؍‬ 9), the glucose infusion was adjusted to maintain blood glucose at 10 mmol/l (hyperglycemic clamp) over 2 h. Group C consisted of five volunteers who were studied as the control group. Peripheral blood mononuclear cells (PBMCs) were isolated before and at the end of a 2-h clamp. In group C, PBMCs were isolated before and after 2 h without performing a clamp. The euglycemic clamp as well as "no clamp" had no effects on all parameters studied. In contrast, a significant increase in carboxymethyllysine ( 
H
yperglycemia is the driving force of late diabetic complications (1) . Activation of nuclear factor (NF)-B in mononuclear cells represents one step in the development of late vascular diabetic complications. The short-lasting postprandial hyperglycemia is associated with changes of vascular function and presumably arteriosclerosis (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Therefore, we studied whether a short-lasting hyperglycemia results in similar changes in mononuclear NF-B activation, as it has recently been described for chronic hyperglycemia or the in vivo effects of AGEs (15) (16) (17) . Several pathways activated by hyperglycemia and leading to changes in cellular functions have been described, including formation of AGEs, generation of free radicals, activation of protein kinase C (PKC), a shift in the polyol pathway, and others (18 -26) . Recently, several studies have shown that an acute increase in blood glucose may, via generation of reactive oxygen species, impair the physiological homeostasis of many systems (2, 3) . Hyperglycemia alters the balance of generation of free radicals and antioxidants, which explains the increase of endothelial cell adhesion molecules in type 2 diabetic patients (4) (presumably via NF-B) or the suppression of flow-mediated endotheliumdependent vasodilation (5, 6) . Several studies in vitro and in vivo support the concept that short-lasting hyperglycemia leads to endothelial cell dysfunction (7) (8) (9) (10) , activation of NF-B in vascular smooth muscle cells (10) , activation of coagulation (11, 12) , and increased generation of free radicals (13, 14) . Most of these studies have looked at the biological effect of postprandial hyperglycemia and its reversal by antioxidants (9) . Radicals are known to impair NO in endothelial cells and to mediate activation of coagulation via NF-B-driven transcription of tissue factor (27, 28) . The mechanisms through which acute hyperglycemia exerts these effects may be identified in several test systems looking at the production of free radicals by the study of reaction products (2, 29, 30, 31) . Furthermore, it has been postulated that hyperinsulinemia generated via hyperglycemia inhibits NF-B in mononuclear cells (15) .
While molecular markers of oxidative stress are indirect, more downstream targets of reactive oxygen species are more easily detected. These include redox-triggered formation of N ⑀ -(carboxymethyl)lysine (CML), which, in addition to binding to its receptor RAGE (receptor for AGE), induces and reflects intracellular generation of radicals, but also activates the ras pathway and induces p42/p44 mitogen-activated protein kinase (MAPK) phosphorylation (32) (33) (34) (35) (36) (37) . Free radical-triggered signal transduction can, at least in most cell types studied, lead to activation of the redox-sensitive transcription factor NF-B. The recent development of a tissue culture independent electrophoretic mobility shift assay (EMSA)-based NF-B-activation detection system allows the detemination of NF-B activation in ex vivo-isolated circulating blood mononuclear cells (38, 39) . NF-B activation has been shown to correlate with HbA 1c and albuminuria (39, 40) , indicating that hyperglycemia induces in vivo signal transduction pathways leading to activation of NF-B.
However, the biochemical situation in diabetes is rather complex, thus making it difficult to recognize the exact molecular pathways involved in NF-B activation and to separate the direct effect of hyperglycemia from other metabolic disturbances of diabetes (including treatment). Therefore, we used normo-and hyperglycemic clamp conditions in healthy volunteers in order to evaluate whether acute hyperglycemia induces signal transduction pathways resulting in NF-B activation. In addition, in vitro studies were performed to elucidate the functional significance of the signal transduction pathways activated by hyperglycemia for activation of NF-B and subsequent NF-B-dependent gene activation.
Preparation of peripheral blood mononuclear cells. Peripheral blood mononuclear cells (PBMCs) were separated immediately after venipuncture as previously described in detail (38, 39) . Whole blood (10 ml), anticoagulated with 3.8% sodium citrate (9:1; vol/vol), was loaded carefully onto Ficoll Paque Plus gradient (Pharmacia, Freiburg, Germany) and centrifuged for 30 min at 500g without brakes at room temperature. The PBMC-containing band was aspirated and the cells were washed three times in PBS, pH 7.4, at 4°C. These prepared PBMCs were immediately quick-frozen at Ϫ80°C and stored. Preparation of nuclear proteins. Nuclear proteins were prepared as described previously (38 -40) . To prepare nuclear extracts, 1 ϫ 10 6 PBMCs were lysed in 200 l ice-cold buffer A (10 mmol/l HEPES-KOH, pH 7.9, at 4°C, 1.5 mmol/l MgCl 2 , 10 mmol/l KCl, 0.5 mmol/l diothiothreitol [DTT], and 0.2 mmol/l phenylmethylsulfonyl fluoride [PMSF]), incubated on ice and centrifuged for 30 s at 15,000 rpm in a table centrifuge. The supernatant was discarded and the nuclear pellet was resuspended in 100 l ice-cold buffer B (20 mmol/l HEPES-KOH, pH 7.9, at 4°C, 25% glycerol, 1.5 mmol/l MgCl 2 , 420 mmol/l NaCl, 0.2 mmol/l EDTA, 0.5 mmol/l DTT, and 0.2 mmol/l PMSF), incubated on ice for 20 min, and centrifuged for 2 min as above. The supernatant containing nuclear proteins was immediately shock-frozen at Ϫ80°C and stored until the next step of the determination of NF-B was started. The protein concentration in the supernatant was determined according to the Bradford method by using a protein measuring assay (BCA assay) (43) . EMSA. EMSA was performed essentially as previously described (39, 40, 44) using 10 g of nuclear extract. Binding of NF-B to 1 ng of radiolabelled NF-B consensus oligonucleotides (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј; ϳ50,000 cpm [Ceré nkov]) and binding of OCT-1 to 1 ng of radiolabelled OCT-1 consensus oligonucleotides (5Ј-TGT CGA ATG CAA ATC ACT AGA A-3Ј; ϳ50,000 cpm [Ceré nkov]) were performed for 20 min at room temperature in 10 mmol/l HEPES, pH 7.5, 0.5 mmol/l EDTA, 100 mmol/l KCl, 2 mmol/l DTT, 2% glycerol, 4% Ficoll, 0.25% NP-40, 1 mg/ml BSA, and 0.1 g/l poly dI/dC for NF-B and for 20 min by room temperature in 10 mmol/l Tris (pH 7.5) buffer with 50 mmol/l NaCl, 1 mmol/l DTT, 1 mmol/l EDTA, 5% glyzerol, and 0.1 g poly dI/dC for Oct-1. Protein DNA complexes were separated from the unbound DNA probe by electrophoresis through 5% native polyacrylamide gels containing 3.25% glycerol and 0.5 ϫ TBE (Tris-Borate-EDTA). Specifity of binding was ascertained by competition with a 160-fold molar excess of unlabelled NF-B and Oct-1 consensus oligonucleotides (38, 39) . Characterization of the NF-B subunits, contributing to the observed shift, was performed by applying 2.5 g of anti-p65, anti-p50, anti-p52, anti-cRel, and anti-relB antibodies into the binding reactions with nuclear extracts of isolated mononuclear cells. Densitometric quantification of NF-Bp65-and Oct-1 binding activity in EMSA. Gels were dried under vacuum and exposed for 12-96 h to films at -80°C with intensifying screens. The resulting NF-B and Oct-1 signals were quantitated by densitometry. Determination of the signal area to be measured and the quantitative evaluation were performed twice for two independent experiments. The mean of the two measurements was taken for statistical analysis. First blood sample taken before clamp was determined and defined as baseline (100%). Western blot analysis of N ⑀ -CML-modified proteins. The cytoplasmic fraction was prepared as previously described in detail (20, 44) . Five micrograms of cytoplasmic extracts were separated onto 10% SDS-PAGE followed by electroblotting to ECL-nitrocellulose membranes. Equal loading was confirmed by Ponceau Red staining. Blocking was performed overnight at 4°C in 0.2% casein (I-Block; Tropix, Bedford, MA) and dissolved in Tris-buffered saline (TBS) supplemented with 0.1% Tween (TBST). Membranes were incubated with primary antibodies against CML diluted 1:8,000 in blocking solution for 45 min at room temperature. After washing (2 ϫ 15 min in TBST, 0.05% Tween), the secondary antibody (horseradish peroxidase-coupled rabbit IgG, 1:3,000) was added and incubation was continued for 30 min at room temperature. Membranes were washed 3 ϫ 15 min as above, followed by detection of immunoreactive proteins using the ECL Western blot system (Amersham, Braunschweig, Germany) using exposure times from 10 s to 1 min. Western blot analysis of p42/44 MAPK (Thr202/Tyr204). The cytoplasmic fractions were prepared as previously described in detail (20) . Ten micrograms of cytoplasmic extracts were separated onto 10% SDS-PAGE, followed by electroblotting to ECL-nitrocellulose membranes. Equal loading was confirmed by Ponceau Red staining. Membranes were incubated with primary antibodies against p42/p44 MAPK (1:1,000) for 180 min at room temperature. After washing (3 ϫ 5 min in TBS, 0.05% Tween), the secondary antibody (horseradish peroxidase-coupled rabbit IgG, 1:2,000) was added, and incubation was continued for 60 min at room temperature. Membranes were washed 3 ϫ 5 min as above, followed by a last 5-min wash in TBS, 0.05% Tween. Immunoreactive proteins were detected with diluted LumiGLO solution and underwent subsequent exposure for 10 -30 s.
Western blot analysis of p21
ras . The cytoplasmic fractions were prepared as previously described in detail (20) . Ten micrograms of cytoplasmic extracts were separated onto 12% SDS-PAGE, followed by electroblotting to ECLnitrocellulose membranes. Equal loading was confirmed by Ponceau Red staining. Membranes were incubated with primary antibodies against p21 ras (1:3,000) for 60 min at room temperature. After washing (3 ϫ 10 min in TBS, 0.05% Tween), the secondary antibody (horseradish peroxidase-coupled mouse IgG, 1:2,000) was added, and incubation was continued for 60 min at room temperature. Membranes were washed 3 ϫ 10 min as above, followed by detection of immunoreactive proteins using the ECL Western blot system (Amersham) using exposure times from 10 s to 1 min. Western blot analysis of NF-Bp65 and IB␣. Cytoplasmic and nuclear fractions were prepared as previously described in detail (20) . Twenty micrograms of cytoplasmic extracts or 10 g of nuclear extracts were separated onto 10 -12% SDS-PAGE, followed by electroblotting to ECLnitrocellulose membranes. Equal loading was confirmed by Ponceau Red staining. Membranes were incubated with primary antibodies against NF-Bp65 and IB␣ for 60 min at room temperature. After washing (2 ϫ 7 min in TBS, 0.05% Tween), the secondary antibody (horseradish peroxidase-coupled rabbit IgG, 1:2,000) was added and incubation was continued for 30 min at room temperature. Membranes were washed 3 ϫ 5 min as above, followed by a last 5-min wash in TBS. Immunoreactive proteins were detected with the ECL-Western blot System, and subsequent exposure was for 2 min (NF-Bp65) and 4 min (IB␣). Densitometric quantification of Western blot autoradiograms. Signals obtained in Western blot analysis were quantified using a GS-700 imaging densitometer (BioRad, Munich, Germany). Determination of the signal area to be measured and the quantitative evaluation were performed twice for two independent experiments. The mean of the two measurements obtained for each patient sample was taken for statistical analysis. The first blood sample taken before clamp was determined and defined as baseline (100%). PBMC stimulation. PBMCs from healthy volunteers were separated immediately after venipuncture as described above, stimulated with glucose (5 or 10 mmol/l) in DMEM, and incubated with selective inhibitors of MAPK (PD 98059) (30 mol/l) and ras (AFC) (50 mol/l), a phosphatase inhibitor (ocadaic acid) (100 nmol/l), and the solvent DMSO (1:1,000) over 2 h. After 120 min, cells were harvested and nuclear proteins were prepared as described in the preceding sections. Ten micrograms of each nuclear extract were analyzed by EMSA for binding activity of NF-B to an NF-B consensus motif. Transient transfection of bovine endothelial cells. For transfection, bovine endothelial cells in concentrations of 2 ϫ 10 5 ml per well were seeded in DMEM supplemented with 10% FCS. One microgram of the appropriate plasmids/well was transfected by the Effectene method. Cells were exposed for 48 h to the precipitate consisting of 100 l condensation buffer, 3.2 l enhancer, 10 l Effectene reagent, and the respective DNA diluted in 2 ml DMEM supplemented with 10% FCS and ␤-mercaptoethanol. Plasmid DNA used in transfections was isolated by Quiagen midi prep columns. To correct for transfection efficiency, 0.05 g pSV-␤-Gal plasmid/well were included. The ␤-galactosidase control plasmid "pSV-␤-Gal" was obtained from Promega, (Heidelberg, Germany). The plasmid "NF-B-Luc" was obtained from Clon- tech (Heidelberg, Germany). For the times indicated in the figure legend, transiently transfected bovine endothelial cells were stimulated with glucose (5 or 10 mmol/l) and incubated with selective inhibitors of signal transduction pathways (see above). After 48 h, cells were harvested in the appropriate buffers. Cell extracts were prepared by lysis in 25 mmol/l Tris phosphate, pH 7.8, 2 mmol/l DTT, 2 mmol/l 1,2-diaminocyclohexane-N,N,N,NЈ-tetraacetic acid, 10% glycerol, and 1% Triton X-100 and were assayed directly for luciferase activity (20) . ␤-galactosidase activity was determined in the same lysis buffer. Luciferase and ␤-galactosidase activity were determined for each sample. The ratio of luciferase activity to ␤-galactosidase activity served to normalize for transfection efficiency (45) . Each experiment was performed in triplicate. The data presented are the mean of transfections performed in triplicate (46, 47) . Statistical analysis. Data are given as means Ϯ SD/͌n. For densitometric evaluation of EMSA results and Western blot signals, Student's two-tailed t test was used to determine significance. P Յ 0.05 was considered to be statistically significant.
RESULTS

Formation of intracellular CML-modified proteins.
Eighteen nondiabetic healthy volunteers were studied. They were divided into two groups of nine volunteers each: group A (euglycemic clamp) and group B (hyperglycemic clamp). Fasting blood glucose, fasting insulin, HbA 1c , and BMI did not differ significantly (Table 1) . Cytoplasmic fractions of ex vivo-isolated PBMCs were obtained at 0 min before and at 120 min at the end of the euglycemic or hyperglycemic clamp. CML modification of proteins was studied as a marker indicating generation of intracellular oxidative stress. In all PBMCs, we observed a major CML-positive band migrating with the molecular weight of 54 kDa. The first blood sample taken before clamp was used as baseline and defined as 100%. No difference in the CML antigen content was found in ex vivo-isolated PBMCs of group A studied before and after euglycemic clamp (Fig. 1A) . When the cytoplasmic extract of PBMCs was studied before and after hyperglycemic clamp (Fig. 1B) , a different picture evolved, since a significant increase in CML content was seen (from 100 to 173%; P ϭ 0.03). CML (reflecting generation of intracellular oxidative stress) and reactive oxygen species themselves have both been previously shown to mediate ras activation and p42/44 MAPK phosphorylation (36) . Activation of signal transduction pathways. We examined p21 ras as downstream effector pathway in a euglycemic and hyperglycemic clamp. While the euglycemic clamp had no effect ( Fig. 2A top and bottom) , the p21 ras activity increased significantly in the hyperglycemic clamp from 100 to 139% (P ϭ 0.04) (Fig. 2B) . In addition, we studied p42/p44 MAPK phosphorylation in a euglycemic and hyperglycemic clamp. There was no significant change in p42/p44 MAPK phosphorylation during the euglycemic clamp (Fig. 2C) , while p42/p44 MAPK phosphorylation increased significantly after hyperglycemic clamp from 100 to 203% (P ϭ 0.02) (Fig. 2D) . Activation of NF-B. Reactive oxygen species, activation of ras, and p42/p44 MAPK phosphorylation have previously been shown to result in activation of NF-B (20, 36, 47) . Therefore, nuclear extracts from PBMCs were prepared and the NF-B binding activity was measured in group A (euglycemic clamp) (Fig. 3A) or group B (hyperglycemic clamp) (Fig. 3B ) using a tissue culture-independent detection system. The resulting NF-B signals were quantitated by densitometry. At baseline, NF-B was comparable in both groups (data not shown). No significant change in NF-B binding activity was observed in PBMCs before and after the euglycemic clamp (Fig. 3A) . In the hyperglycemic clamp, the NF-B binding activity changed significantly (Fig. 3B) . The average NF-B binding activity was 100% at 0 min and increased to 149% after 120 min (P ϭ 0.04) (Fig. 3B, bottom) . The transcription factor Oct-1 served as control, and its binding activity remained constant in group A (P ϭ 0.29) (Fig. 3C ) and group B (P ϭ 0.85) (Fig. 3D) .
In group C, the control group, consisting of five healthy volunteers, there was no significant change in cytoplasmic CML content (Fig. 4A) , no significant NF-B-p65-antigen translocation into the nucleus (Fig. 4B) , and no signifcant activation of ras (Fig. 4C) or p42/44 MAPK phosphorylation (Fig. 4D ) assayed by Western blot was observed at 0 min and at 120 min without doing a clamp.
To identify the NF-B-subunits that contribute to the observed shift, anti-p65, anti-p50, anti-p52, anti-cRel, and anti-relB antibodies were added to the binding reaction. As demonstrated in Fig. 5 , NF-B-p50 and NF-B-p65 bind to the NF-B consensus motif, whereas p52, cRel, and RelB showed no effect. Furthermore, we observed no change in the relative contribution of p50 and p65 before (Fig. 5A ) and after hyperglycemic clamp (Fig. 5B) .
To confirm the participation of NF-B-p65 in the hyperglycemia-induced NF-B activation, the translocation of NF-B-p65 into the nucleus was studied. Nuclear and cytoplasmic fractions obtained from group A or B at 0 min before and at 120 min after euglycemic or hyperglycemic clamp were separated by SDS-PAGE and subjected to immunoblotting with an antibody for NF-B-p65-antigen (Fig. 6) . The first blood sample taken before clamp was defined as 100%. While nuclear NF-B-p65-antigen did not change significantly in euglycemic clamp (Fig. 6A) , Western blot analysis confirmed the EMSA results by showing an increase from 100 to 201% in nuclear NF-B-p65-antigen after hyperglycemic clamp (P ϭ 0.05) (Fig. 6B) . Western blot analysis for NF-B-p65 in cytoplasmic extracts obtained at 120 min in euglycemic clamp did not change significantly (Fig. 6C) , while Western blot analysis for
FIG. 3. NF-B and Oct-1 binding activity in PBMC before and after euglycemic or hyperglycemic clamp. NF-B binding activity in nuclear extracts of PBMCs before and after a euglycemic (A) or hyperglycemic (B) clamp. A representative patient is shown on top, and the result of the whole group (؎ SD͌n) is shown on bottom. Oct-1 binding activity in the euglycemic clamp (C) and Oct-1 binding activity in the hyperglycemic clamp (D)
. Each EMSA signal obtained before and after clamp was quantitated by laser densitometry. The first blood sample taken before clamp was determined and defined as baseline (100%). Determination of the signal area to be measured and the quantitative evaluation were performed twice for two independent experiments. The mean of the two measurements was taken for statistical analysis.
NF-B-p65 from cytoplasmic extracts obtained at 120 min resulted in a significant decrease of NF-B-p65 from 100 to 86% (P ϭ 0.03) in hyperglycemic clamp (Fig. 6D) . These data indicate the translocation of NF-B-p65 from the cytoplasma to the nucleus during hyperglycemic clamp.
Previous data in patients with newly manifested type 1 diabetes and in vitro data using AGE proteins as inducers of NF-B activation showed that, in these models, NF-B activation is not associated with loss of IB␣-antigen (20) . There was also no change in cytoplasmic IB␣-antigen before and after a euglycemic ( quences of these findings, we used in vitro conditions to elucidate the signal transduction cascade controlling hyperglycemia-mediated mononuclear cell activation. PBMCs isolated from healthy volunteers showed an increased NF-B binding activity when glucose was raised from 5 to 10 mmol/l with or without insulin over 2 h (corresponding to the conditions used in the clamp studies) (Fig. 8A) .
The in vitro studies showed with respect to CML content (Fig. 8B) , actvation of ras (Fig. 8C) , and p42/p44 MAPK phosphorylation (Fig. 8D) essentially the same results as in the clamps. Furthermore, we did not see an effect of insulin on the hyperglycemia-induced changes, which indicates that the presence of insulin was not responsible for the lack of cell activation in the euglycemic clamp of group B.
When inhibitors of different signal transduction pathways were added, an inhibition of hyperglycemia-mediated NF-B activation was seen using the ras inhibitor AFC (50 mol/l) and the inhibitor of MAPK PD 98059 (30 mol/l) (Fig. 9A ) or using GF 109203X (5 mol/l), thioctic acid (1 mmol/l), aminoguanidin (10 mmol/l), or FCCP (0.5 mol/l) (Fig. 9C) . No inhibition was seen using ocadaic acid or DMSO as solvent (Fig. 9A) .
Bovine endothelial cells (we did not achieve reliable transfection efficiency in ex vivo-isolated PBMCs) were transiently cotransfected with an NF-B-p65-driven luciferase construct and, in order to control for transfection efficiency, with pSV-␤-Gal plasmid to demonstrate functional significance of glucose-dependent NF-B translocation ( Fig. 9B and D) . Part of the cells were either left in 5 mmol/l or were stimulated with 10 mmol/l glucose. The latter increased NF-B transcriptional activity, showing that the increase in NF-B activation found after 2 h of hyperglycemia results in increased NF-B-dependent gene transcription and translocation. PD 98059 (30 mol/ l), AFC (50 mol/l) (Fig. 9B ), GF 109203X (5 mol/l), thioctic acid (1 mmol/l), aminoguanidin (10 mmol/l), and FCCP (0.5 mol/l) (Fig. 9D ), but not ocadaic acid or the solvent DMSO (Fig. 9B) , reduced NF-B transcriptional activity induced by 10 mmol/l glucose, corresponding to the data shown in Fig. 9A or Fig. 9C and the data obtained in volunteers. Thus, hyperglycemia-mediated signaling via ras and MAPK does not only induce NF-B activation but also transcriptional activity.
DISCUSSION
Hyperglycemia is a driving force of late diabetic complications, making it necessary to understand not only indi- rect effects of glucose, such as the AGE-mediated cellular effects, but also direct effects of glucose. Several studies have shown that even an acute increase in blood glucose may impair the physiological homeostasis of many systems (2,3), such as the balance of free radicals/antioxidants. Furthermore, hyperglycemia increases adhesion molecules such as intracellular adhesion molecule (ICAM)-1 in type 2 diabetic patients (4), augments leukocyte-endothelial interaction (48) , and suppresses flowmediated endothelium-dependent vasodilation of brachial artery (6, 7) . This is explained by an overshoot of superoxide anions resulting in increased nitric oxide degradation. The mechanisms through which acute hyperglycemia exerts these effects may be the production of free radicals.
As shown in the present study, the formation of free radicals can be detected on the molecular level by the activation of the redox-sensitive transcription factor NF-B as an end point of a hyperglycemia-mediated ROSras-MAPK signaling pathway. Thus this study exceeds the data previously presented and published (10, (15) (16) (17) not only by showing the in vivo relevance, but also by correlating these in vivo data in healthy, nondiabetic subjects during euglycemia and acute (2 h) hyperglycemia resulting from euglycemic and hyperglycemic clamp to in vitro data showing intracellular intracellular formation of AGEs (CML) and activation of ras, p42/44 MAPK, and NF-B in PBMCs.
In our study the average NF-B binding activity in hyperglycemic clamp increased in each volunteer significantly, while in the euglycemic clamp the average NF-B binding activity did not change.
This was not due to the insulin present in the hyperglycemic group, since insulin did not at the dose of 250 U/ml affect NF-B activation in vitro and since the 2 h NF-B activation was similar in the control and euglycemic clamp volunteers. Furthermore hyperglycemia-mediated ROS generation resulted in significantly elevated cytoplasmic CML content, a cytoplasmic marker of oxidative stress (35, 37) , while euglycemic clamp had no effect. The question whether intracellular CML accumulation is only a marker of redox-dependent protein modification or whether it has in addition direct biological effects such as RAGE-dependent NF-B activation remains unclear (20, 35, 46, 49, 50, 51) . Intracellular CML-dependent signaling or transport of CML-modified proteins outside the cell and subsequent engagement of RAGE have not been described.
However, the inhibition of NF-B activation and the inhibition of intracellular AGE formation by aminoguanidin, an inhibitor of electron transport chain complex II, an uncoupler of oxidative phosphorylation, uncoupling protein-1, or manganese superoxide dismutase (35, 52, 53) allows us to speculate that intracellular CML is directly involved in signaling. This indicates that there may be several other membrane-associated CML binding proteins that are capable of binding intracellular CML and thereby coupling intracellular CML to signal transduction. In support of this hypothesis, we have recently observed that RAGE-blocking antibodies significantly reduce AGE-dependent NF-B activation in vivo, but they do not block completely (A.B., P.P.N., unpublished observations). Thus, a concept emerges in which the indirect effects of glucose that lead to extracellular AGE-RAGE signalling, combined with the direct intracellular effects of glucose, contribute to late diabetic complications.
Nevertheless, acute hyperglycemia seems to induce the generation of oxidative stress in healthy nondiabetic volunteers, leading to a detectable increased accumulation of CML in the cytoplasm of PBMCs. The in vivo studies show that hyperglycemia rapidly induces intracellular CML. This corresponds well to previous studies that have showed rapid intracellular AGE formation (19, 54) . Hyperglycemia increases production of reactive oxygen species inside cultured endothelial cells, which can be prevented by an inhibitor of electron transport chain complex II, an uncoupler of oxidative phosphorylation, uncoupling protein-1, or manganese superoxide dismutase (35) . Normalizing mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of AGEs, and activation of the transcription factor NF-B (35) .
NF-B activation caused by chronic hyperglycemia has previously been shown in patients with type 1 diabetes to represent oxidative stress, and it correlates with HbA 1c and albuminuria (39, 40) . Our data extend this concept by showing in vivo that a 2-h hyperglycemia is sufficient for activation of the ras-MAPK-pathway and nuclear translocation of NF-B-p65. It has previously been reported that MAPK activity is increased upon addition of free radical reporters (36) , and activation of a family of Ser/Thr kinases seems to be one of the known critical intermediates in signal transduction by p21 ras that occurs typically very early in cellular activation (36) . Our observations indicate that this is indeed the case during acute hyperglycemia in PBMCs isolated from healthy volunteers. The in vitro studies presented here add to the in vivo associations, showing that ras activation and p42/p44 MAPK phosphorylation are indeed causative for hyperglycemiamediated activation and transcriptional activity of NF-Bp65 not depending on insulin.
Thus, we better understand the role of processes set in motion during acute hyperglycemia, an event that culminates in intracellular CML formation, activation of ras, p42/44 MAPK phosphorylation, and increased NF-B binding and transcriptional activity in monocytes, three biochemical pathways seemingly involved in the pathogenesis of diabetic complications and supported by studies in which pathway-specific inhibitors prevent various hyperglycemia-induced abnormalities (35) .
